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Abstract
Background: In this single-site study, we evaluated the feasibility of a parent-clinician communication inter-
vention designed to: identify parents’ rationale for the phase I, do-not-resuscitate (DNR), or terminal care
decision made on behalf of their child with incurable cancer; identify their definition of being a good parent to
their ill child; and provide this information to the child’s clinicians in time to be of use in the family’s care.
Methods: Sixty-two parents of 58 children and 126 clinicians participated. Within 72 hours after the treatment
decision, parents responded to 6 open-ended interview questions and completed a 10-item questionnaire about
the end-of-life communication with their child’s clinicians. They completed the questionnaire again two to three
weeks later and responded to three open-ended questions to assess the benefit:risk ratio of their study partici-
pation three months after the intervention. Clinicians received the interview data within hours of the parent
interview and evaluated the usefulness of the information three weeks later.
Results: All preestablished intervention feasibility criteria were met; 77.3% of families consented; and in 100% of
interventions, information was successfully provided individually to 3 to 11 clinicians per child before the child
died. No harm was reported by parents as a result of participating; satisfaction and other benefits were reported.
Clinicians reported moderate to strong satisfaction with the intervention.
Conclusion: The communication intervention was feasible within hours of decision making, was acceptable and
beneficial without harm to participating parents, and was acceptable and useful to clinicians in their care of families.
Introduction
Parents of children with incurable cancer report thatachieving their internal definition of being a good parent
to their seriously ill child helps them to emotionally survive
the dying and death of their child.1–3 Parenting their child at
the end of life can include participating in making decisions
such as whether to enroll their child in an experimental agent
study, agree to a do-not-resuscitate (DNR) status, or end all
disease-directed treatment and initiate terminal care for their
child. Tension between parents and clinicians that is related to
end-of-life decision making can emerge when differences exist
about preferred care options.4–6 Clinicians’ reactions to parent
preferences directly influence parents’ sense of competence as
parents at a time when they have few remaining opportunities
to function as their child’s parent.7 Parents have reported
needing to receive positive feedback from clinicians about the
wisdom of their decisions and acknowledgement that they are
making good decisions at the end of their child’s life.8 Ad-
ditionally, clinicians’ reactions to parent preferences can influ-
ence parental trust of clinicians at a time when trust is essential
to best meet the care needs of the seriously ill child and to
facilitate any subsequent care decision making.7,9,10 When well
informed of the decision and the rationale for it clinicians are
more likely to be supportive of parental preferences for end-of-
life care options;11 having this information also decreases the
likelihood of clinicians experiencing moral distress.12–14
The study proposed to assess the feasibility of a parent-
clinician end-of-life communication intervention. Interven-
tions were to provide clinicians with parents’ statements of
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understanding about the end-of-life decision made, the op-
tions they considered, their rationale for the option chosen,
and their definition of being a good parent to their seriously ill
child. The study sought to determine the clinician behaviors
that could help parents to achieve their definition of being a
good parent. Assessment was made of parents’ perceptions of
the acceptability and clinicians’ of the usefulness of the in-
tervention. The study was guided by the Pediatric Quality of
Life at End-of-Life model.15 This model includes factors that
influence parental understanding of their child’s transition to
end of life, including information from trusted clinicians, the
parents’ definition of being a good parent to their ill child, the
child’s apparent symptoms and altered physical appearance,
and information indicating that no scientific advances remain
to help their child survive the illness.16–18
Methods
Inclusion criteria for parents were the following: the parent of
a child with incurable cancer receiving care at the study site who
had participated in making a decision within the previous 72
hours about either (1) enrolling the child on a phase I experi-
mental agent study, (2) initiating a do-not-resuscitate (DNR)
order, or (3) ceasing disease-directed treatment and initiating
terminal care; at least 19 years of age; English-speaking; and
willing to give written consent. Parents were ineligible if their
child’s physician, nurse, or psychosocial team expert (social
worker, childlife worker, psychologist) identified them as being
emotionally or mentally unable to participate in an informed
consent process or likely to find the study to be too burdensome
because of their emotional or mental state.
Inclusion criteria for clinicians (i.e., attending, fellow, reg-
istered nurse, advanced practice nurse, pharmacist, social
worker, child life worker, nursing care assistant) included the
following: directly involved in the care of the child for whom
an end-of-life treatment decision had been made in the pre-
vious 72 hours, English-speaking, and willing to give written
consent. Parents were enrolled only once, but clinicians could
be enrolled multiple times during the study period if parents
of their other patients became eligible for the study.
The study had a single-site, feasibility, pre-post commu-
nication intervention design. The design had five data-
collection time points (see Fig. 1):
T1: Parent eligibility was confirmed, and parents were
informed of the study’s purpose.
T2: Study forms were completed during face-to-face in-
terviews with parents.
T3: Clinicians completed a baseline questionnaire about
the decision. With parental permission, the parents’
interview responses were then disseminated to available
clinicians orally by the study team member, and the
written interview was then placed in the child’s medical
record to provide access to all involved clinicians.
T4: Clinicians’ perceptions of acceptability and usefulness
of the communication intervention were solicited ap-
proximately three weeks after they received the parent
interview information.
T5: Parents’ perceptions of the communication interven-
tion and study participation were solicited approxi-
mately 12 weeks after their participation in the study.
End-of-life decisions were identified during daily clinical
rounds by a study team member from each clinical team, re-
view of daily physician documentation and orders in high
acuity clinical areas (intensive care unit, bone marrow trans-
plant unit), and by electronic notification from the central
protocol and data management office when patients were
enrolled in a phase I study. Parent eligibility was then con-
firmed individually by the attending physician, a psychoso-
cial expert, and a nurse. If the three sources disagreed, then
the study team asked them to discuss their opinions and
render a final decision about parent eligibility. Five dis-
agreements occurred and were resolved after discussion with
the involved clinicians.
The intervention (T2) included the study team member ad-
ministering the Parent Perceptions of End-of-Life Commu-
nication with Staff Form to each participating parent. This form,
developed for this study, is composed of 10 items from the
Study to Understand Prognoses and Preferences for Outcomes
and Risks of Treatment (SUPPORT) Study19 and the Satisfaction
with Decision Instrument20 and 2 additional items related to
parents’ perceptions of achieving their definition of being a
good parent to their seriously ill child. The second form ad-
ministered to each parent was the Parent-Clinician Commu-
nication Form at the Time of Difficult Decision Making, a 6-item
interview guide composed of 4 previously tested questions in
end-of-life decision-making studies and 2 additional questions
about being a good parent at the end of life.1,21,22 The basis of the
questions was explained to each participating parent. The in-
terview questions were:
1. Please tell me in your own words what the treatment
decision was that you helped to make for your child.
2. Please tell me the options that you considered when
you helped to make this decision.
FIG. 1. Study Design Schema (T1 – T5).
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3. Please list who was in the room with you when the
decision was made.
4. Please tell me about your reason/s for choosing this
option.
5. Please share with me your definition of being a good
parent for your child at this point in your child’s life.
6. Please describe for me the actions from staff that would
help you in your efforts to be a good parent to your
child now.
Clinicians completed a 6-item questionnaire, Staff Percep-
tions of End-of-Life Communications, at T3 and T4. Four
items had response options of ‘‘rarely,’’ ‘‘almost half the time,’’
and ‘‘almost always;’’ 2 items had ‘‘agree/disagree’’ response
formats. At T4, clinicians responded to 6 additional items
about their recall of the information shared during the com-
munication intervention and their perception of the useful-
ness of that information; they also answered the open-ended
question, ‘‘How did the information influence your practice or
your interactions with this family?’’
At T5, parents were asked three questions during a tele-
phone follow-up contact initiated by a study team member
who was not a part of the intervention:
1. What was good about being in the study?
2. What was bad about being in the study?
3. What else would you like us to know?
Statistical considerations
The study definition of feasibility was at least 60% of eligible
parents would consent to participate and at least 60% of par-
ticipating parents and their child’s clinicians would be able to
complete the communication intervention before the child died.
Parent and clinician responses to the questionnaire items were
analyzed using descriptive statistics. Change in the parent scores
was not assessed because of the high (ceiling) scores of satis-
faction at both measurement points. Change in clinician scores
on the Staff Perceptions of End-of-Life Communications Ques-
tionnaire was assessed at the individual item level using percent
change and the Kappa statistic of agreement. Two members of
the study team independently rated the clinician responses for
recall accuracy of the parent interview data, and percent agree-
ment was subsequently calculated. Two team members inde-
pendently rated the clinician responses to the open-ended
question to achieve a minimum of 80% agreement with coding
of the clinician responses.
Results
During the 22-month study enrollment period, 232 eligible
end-of-life decisions were identified at the study setting. Of
these, 91 (39.2%) decisions were identified after the family had
exited the study site to return to their homes and had no return
appointment planned (see Fig. 2). Sixty-six decisions were inel-
igible with the two most common reasons being clinician per-
ception of the parent being too vulnerable to participate (n = 27)
and the parent being non–English speaking (n = 24).
Parent participation rates
Of the 75 eligible families, 62 (77.3%) parents of 58 seriously
ill children enrolled in the study (see Table 1), and 17 parents
(21.5%) declined. Of the 17 parents who declined, 9 (52.9%)
had made a DNR decision; 6 (35.3%), a phase I decision; and 2
(11.8%), a terminal care decision. The primary reasons for
refusal were ‘‘no time now to participate’’ (n = 8), with 3
families asking to participate after they had returned to their
homes, and ‘‘too hard to do this now’’ (n = 5).
FIG. 2. Study Enrollment.
Table 1. Characteristics of the Participating











Mean (sd) 37.6 (7.8)
Median (range) 38.2 (19.7 – 55.2)
Decision made
Yes – phase 1 study 30 (51.7)
No – phase 1 study 0 (0)
Yes – DNR 17 (29.3)
No – DNR 1 (1.7)
Yes – Terminal care 9 (15.5)
No – Terminal care 1 (1.7)
DNR, do not resuscitate; sd, standard deviation
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Clinician participation rates
Of the 139 clinicians involved in the care of eligible families,
126 (90.6%) enrolled in the study; the rest declined to partic-
ipate. The primary reason for clinician refusal was ‘‘not sure
what to do with the information that would be made available
to me’’ (n = 7). Clinicians participated 1 to 10 times in the
study, with the majority of clinicians (88.9%) participating 1 to
3 times. Altogether, the 126 clinicians provided 253 reports at
T3 and 215 reports at T4. Only the clinician reports available at
both T3 and T4 (n = 215) were included in the analysis. The
clinicians providing those reports were nurses (n = 106,
49.3%); psychosocial experts (n = 38, 17.7%); physicians
(n = 22, 10.2%); nurse practitioners (n = 18, 8.4%); nursing care
assistants and unit coordinators (n = 13, 6.1%); fellows (n = 11,
5.1%); and others (pharmacists/physician assistants/volun-
teers) (n = 7, 3.2%). No family withdrew from the study. Ad-
ditionally, the communication intervention was fully
delivered to each participating parent and clinician before the
child’s death. These findings support the feasibility of the
communication intervention being delivered within 72 hours
of an end-of-life treatment decision.
Parent and clinician satisfaction with the end-of-life
communication intervention 2 to 3 weeks
after the intervention
Parent-matched reports at T2 and T4 (n = 46) were included
in the analysis of satisfaction with end-of-life decision making.
Of the 10 items reported, 6 were at 97.8% to 100% agreement
at T2; all 10 items reported at T4 were at 95.7% to 100%
agreement, indicating that overall parent satisfaction with
end-of-life decision making and with clinician support for
decision making remained high three months after the inter-
vention. Five parents at T2 indicated agreement with the item,
‘‘If the staff had told me more about my child’s condition, I
would have made a different decision about my child’s care.’’
Of these parents, three had enrolled their child in a phase I
trial, and two had made a DNR decision. Only two of these
parents gave the same response at T4.
Clinician-matched reports at T3 and T4 (n = 215) were in-
cluded in the analysis of satisfaction with the communication
intervention. All item ratings improved slightly from T3 to T4
(improvements ranging from 1.9% to 11.6%). When the cli-
nician responses to the items are considered by type of deci-
sion, the improvements are larger for the phase I and DNR
decisions than for the decision for terminal care (data not
shown). The item across all decisions that received the lowest
clinician ratings and smallest Kappa coefficient was, ‘‘Doc-
umentation about end-of-life decisions is adequate.’’ The item
with the highest percent of ‘‘almost always’’ responses and the
largest Kappa coefficient (0.6014) was, ‘‘It is easy for me to talk
openly with nurses on my team about end-of-life decisions for
our patients’’ (see Table 2). Nursing assistants and unit coor-
dinators (n = 13) reported having the least access to informa-
tion about end-of-life decision making and the least
involvement in the decision-making process; physicians re-
ported having the most access and involvement. In terms of
change between T3 and T4 by discipline, the more positive
scores were reported by nurses and psychosocial experts (data
not shown).
Of the 215 clinician reports at T4, 72.6% were a complete or
a partial match as determined by the two independent raters
Table 2. Clinician Rating Agreement




1. I get accurate information about end-of-life
decisions from my team when I need it.
0.5726
2. It is easy for me to talk openly with the
doctors on my team about end-of-life
decisions for our patients.
0.5291
3. It is easy for me to talk openly with nurses
on my team about end-of-life decisions
for our patients.
0.6014
4. Documentation about end-of-life decisions
is adequate.
0.4946
5. I was involved in the end-of-life decision
for this patient as much as I wanted
to be.
0.4986
6. I would have recommended a different
option.
0.2474
T3, third data point; T4, fourth data point
Table 3. Clinician Perceptions about End-of-Life
Communication Intervention Information at T4
Item n (%)
1. What the parent’s rationale for the
end-of-life decision was.
Match 105 (48.8)
Partial match 51 (23.7)
Mismatch 41 (19.1)
Missing 18 (8.4)
2. What the parent’s definition of being a
good parent was.
Match 91 (42.3)
Partial match 51 (23.7)
Mismatch 51 (23.7)
Missing 22 (10.2)
3. Knowing the parent’s view on the decision




4. Knowing the parent’s rationale for the





5. Knowing the parent’s definition of being a





6. Staff being told the parent’s rationale for
the end-of-life decision or the definition
of being a good parent affected staff




T4, fourth data point
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of the parents’ rationale for the end-of-life decision made; and
66.1% of the reports were a complete or a partial match with
the parents’ definition of being a good parent (see Table 3).
Ninety-three clinician reports (43.3%) indicated that knowing
the parents’ perceptions of the end-of-life decision improved
their interactions with the parent. Additionally, clinician re-
sponses to the query about how the interview information
influenced their practice or interactions with the family were
categorized into five categories, with the largest category
being ‘‘my professional interactions with the parent/s im-
proved’’ (n = 75) (see Table 4). Finally, 29.3% of the clinician
reports indicated that having the information in the commu-
nication intervention helped to reduce tension among clini-
cians about end-of-life decision making. Field notes of
spontaneous comments made by clinicians indicated that 43
reported that no tension around the decision existed and,
therefore, no reduction of tension was possible.
The majority of parental responses (87.5%) to the follow-up
question at T5 about what was good about being in the study
were related to ‘‘helping others.’’ The most frequent parent
response to the question about what was bad about being in
the study was ‘‘nothing’’ (89.2%). Two parents (4.3%) reported
negative aspects: inappropriate timing of being informed
about the study (n = 1) and participating triggered a reliving of
the end-of-life decision making (n = 1). The most frequent
parent response to the interview question about what else
parents wanted clinicians to know was ‘‘nothing else’’ (65.3%)
(see Table 5).
Discussion
Although the number of refusals was small, the refusals
occurred more often in the resuscitation decision category than
in the phase I decision category. This trend may reflect the
number of families in the resuscitation category who wanted
to exit the study setting quickly to take their child home.
Having a mechanism by which to provide information
about end-of-life decision making could be a helpful clinical
Table 4. Categories of Clinician Responses to the Query about Influence of the Parent













Clinicians described having more
awareness of the parent/s’ and/or
patient’s basis for treatment decision
making.
24 ‘‘I was more aware of the family wishes.’’
‘‘I was more aware of how important





Clinicians described using information
from the intervention to guide and
inform their efforts to support the
parent/s, being more comfortable
speaking with parents regarding
changes in treatment, and for some,
increasing their availability and time
spent with the parent/s.
75 ‘‘It increased my commitment to
providing support and helping the
family locate resources for increased
quality of life of the patient.’’
‘‘It helped me to speak openly and to
listen to the parent to assist in caring for





Clinicians described an enhanced respect
and admiration for the parent/s and
more empathy for their clinical
situation.
22 ‘‘I felt deep empathy for this mother
knowing she had to make a choice
between more harsh treatments (her
words) or letting her baby live a normal
life to the end.’’
‘‘Made me more compassionate.’’
My knowledge
increased.
Clinicians reported receiving information
about the clinical or family situation
that they had not previously possessed
and as a result in some situations,
received more personal comfort.
30 ‘‘Let me know they had made an end-of-
life decision that I was unaware of and
let me know what phase they were in
(with) treatment which helped me not
ask unnecessary or improper
questions.’’
‘‘In knowing how knowledgeable she is
about treatment and (her son’s) disease
helped me gear interventions.based
on their exposure to all of this
knowledge.’’
Nothing changed. Clinicians indicated that their interactions
with the parents did not vary after
receiving the information because they
treat all parents with the same respect
and/or they had not had an
opportunity to interact with the parents
after receiving the interview
information.
43 ‘‘It didn’t affect the care or interactions
because each person has his/her own
belief system and values and I am
supportive of that.’’
‘‘It did not – I would give the same level
of care and interaction with the family
no matter what!’’
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tool for clinicians caring for the family members making such
decisions. However, the extent to which these discussions are
documented in the medical record varies and can be limited
by the type of decision made.23 End-of-life documentation has
typically been studied by reviews of medical records. In two
such studies, 35% to 40% of eligible medical records had in-
complete or missing documentation about end-of-life deci-
sions, making these records inevaluable.24,25 In another study,
documentation was described as fragmented and inconsis-
tent.26 Furthermore, many clinicians in our study commented
that they would not have had access to such information
without our intervention.
Clearly, standard documentation in the medical record
does not sufficiently help clinicians understand end-of-life
decisions. In other studies, specific order forms designed to
communicate a treatment-limitation decision to clinicians
have been described by clinicians as significantly improving
the clarity of written orders and the communication between
clinicians, family members, and other clinicians. 27,28 The
parent interview tool we used served as a similarly simple
communication tool and provided the parents’ own words
about the decision, their rationale, and their definition of be-
ing a good parent at the end of their child’s life—as well as
suggesting actions clinicians could take to help parents fulfill
that definition.
Clinician-reported usefulness of the communication inter-
vention included four categories that reflected an increase in
clinician understanding of the family’s reasons for the end-of-
life decision making. These clinician-reported categories di-
rectly address previously published concerns from clinicians
about discussing end-of-life decision making and care for
a child with incurable cancer, indicating that the parent-
clinician intervention improves parent-clinician interac-
tions and communication.29–31 The second largest category,
‘‘nothing changed,’’ contained responses indicating that cli-
nicians either did not allow the information to affect their
interactions with the parents or had no opportunities to use
the information. The study team noted in some clinicians’
verbal responses a seeming sensitivity to the interview ques-
tion, as if they interpreted the question as implying that their
practice or interactions with parents needed to improve. For
future studies, we will revise this question, using more neutral
wording.
Three families who participated in the study contacted the
study team when a second end-of-life decision was made
and asked to participate again because of the benefit of
participating the first time. This unexpected experience
suggests that some parents would consider being part of a
longitudinal prospective study, allowing the study of par-
ents’ perspectives over time and decisions. Our findings also
indicate that only a minority of parents are perceived by
clinicians as being too vulnerable to participate in a com-
munication intervention study after an end-of-life treatment
decision has been made; thus, clinician protection of parents
is not a central barrier to this kind of intervention. Limita-
tions of our study include having only a small number of
fathers in the sample and inflexibility of the method, as only
parents available for face-to-face interviews and who were
English speaking were eligible.
A parent-clinician communication intervention within 72
hours of end-of-life decision making on behalf of a child with
incurable cancer is feasible, acceptable, and beneficial without
harm to participating parents. Such intervention is also ac-
ceptable and useful to clinicians directly involved in the care
of the seriously ill child and family. The focus on the good
parent concept proved to be a positive aspect of the commu-
nication intervention for the participating parents and was
used by some participating clinicians in their clinical care in-
teractions with the parents.
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